Property valuer M3 Property has denied claims that its lease valuations were incorrect and led to tenants of Adelaide’s Rundle Mall being overcharged and says that if it is found liable, brokers CBRE and JLL should be on the hook as well.
German car hire company SIXT has dropped its bid for an injunction barring Darwin International Airport from requiring it to vacate the premises it operates out of at the airport.
An entity associated with the director of defunct Sydney builder Quasar Constructions has failed to hand over details about its assets to liquidators, prompting further orders with a warning from the court.
The ACCC has picked up its review into Acciona’s bid to acquire the $500 million East Rockingham waste-to-energy project in Western Australia, after hitting pause last month.
A judge has signed of on a settlement struck by the liquidator for failed financial services firm Babcock & Brown, which will resolve all remaining and future shareholder disputes, which have beleaguered the liquidator for 12 years.
Cryptocurrency exchanges will be required to hold an Australian Financial Services Licence under proposed legislation announced by assistant treasurer Dr Daniel Mulino.
Saying the appeals court committed “fundamental errors” in approaching their claim of loss, the applicants in failed cases against the Commonwealth Bank have appealed to the High Court, in a case that could clarity the elusive test for damages in shareholder class actions.
Super trustee Macquarie Investment Management has admitted it failed to act efficiently, honestly and fairly after thousands of members invested $321 million in a Keystone fund under investigation for misusing funds.
The Chief Justice of the Queensland Supreme Court has warned lawyers they could be referred to the legal watchdog or face a personal costs order if they file submissions that contain hallucinations produced by generative artificial intelligence.
Abbey Animal Health has managed only a “pyrrhic victory” in a patent case against rival Virbac over an antiparasitic drug, and must withdraw its Levamox Duo product from the market, a court has found.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
